<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-07T11:38:29+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-TJK-T-RCTC-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Fight Against Tuberculosis in Tajikistan - Tajikistan (01-Jan-2016-31-Mar-2018)</narrative>
    </title>
    <description type="1">
      <narrative>Tajikistan, Tuberculosis, Republican Center of Tuberculosis Control - Tajikistan</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To decrease the burden of tuberculosis in Tajikistan by ensuring universal access to timely and quality diagnosis and treatment of all forms of TB. Objectives: To enhance the response to TB epidemic by strengthening involvement of communities, advocacy, communication and social mobilization; To ensure universal access to early and quality diagnosis of all forms of TB including M/XDR-TB; To ensure universal access to quality patient-centered treatment of all forms of TB including M/XDR-TB with appropriate patient support; To provide appropriate TB care for high-risk population groups: prisoners and TB/HIV co-infection; To strengthen the National TB Program management and improve the health system’s performance for effective TB control.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
    </participating-org>
    <other-identifier ref="TJK-T-RCTCP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-01-01" />
    <activity-date type="2" iso-date="2016-01-01" />
    <activity-date type="3" iso-date="2018-03-31" />
    <activity-date type="4" iso-date="2018-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="TJ" percentage="100">
      <narrative>Tajikistan</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="63bfb8d7-70d0-4c58-a18e-b740e390f1de">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-06-21" />
      <value currency="USD" value-date="2016-06-21">2650491.00</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="157ed074-b7e9-4346-a17a-85f7eb404745">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-06-23" />
      <value currency="USD" value-date="2016-06-23">30000.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3f48dada-c560-4fe5-8c30-f1d9e50834c3">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-06-23" />
      <value currency="USD" value-date="2016-06-23">295147.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1c3d41fb-fe4e-4f82-9b69-38ec28514d34">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-11-22" />
      <value currency="USD" value-date="2016-11-22">196693.03</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fc2b95cf-035f-48f9-8926-44fe796ef2b1">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-11-24" />
      <value currency="USD" value-date="2016-11-24">174111.20</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="34fbab20-655a-4e28-a94f-fab6f8e78831">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-01-26" />
      <value currency="USD" value-date="2017-01-26">20000.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3bf09d0d-685d-4a7b-a230-a90da268cd42">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-01-26" />
      <value currency="USD" value-date="2017-01-26">412636.54</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b2d8721b-92c7-48c2-a2bd-a8bc76028b79">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-02-02" />
      <value currency="USD" value-date="2017-02-02">30000.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e77312e0-3996-47b3-b727-fbfbecca5440">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-03-21" />
      <value currency="USD" value-date="2017-03-21">183887.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3ff561c4-35ed-4062-a7fc-540d8f08f25b">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-06-30" />
      <value currency="USD" value-date="2017-06-30">-1308016.23</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a664a01b-1644-4ba0-823f-71d1ee36e96d">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-06-30" />
      <value currency="USD" value-date="2017-06-30">2180841.46</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="66f77a82-4743-49b1-a9ac-0b91605df95a">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-04" />
      <value currency="USD" value-date="2017-07-04">1506523.26</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c437c698-ca8e-49d7-a8e6-40749de410fa">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-04" />
      <value currency="USD" value-date="2017-07-04">200000.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0eb31daa-f543-4f5d-bad4-f1603e820326">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-08-17" />
      <value currency="USD" value-date="2017-08-17">-1506523.26</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7168fac0-a2e5-4ae6-bef5-893e87cb30c8">
      <transaction-type code="7" />
      <transaction-date iso-date="2017-08-17" />
      <value currency="USD" value-date="2017-08-17">1506523.26</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="25dce3b7-fcd2-46db-bf08-d10fd6edb011">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-10-13" />
      <value currency="USD" value-date="2017-10-13">-474318.20</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7c29a36-c920-4b5f-b8e2-6f153adb73fe">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-10-13" />
      <value currency="USD" value-date="2017-10-13">3093282.75</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3309c5cf-2324-4496-bf5a-63b0580217bd">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-10-17" />
      <value currency="USD" value-date="2017-10-17">284213.20</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b8cba4fa-79c9-4c6b-9f76-ec1eb674000b">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-10-17" />
      <value currency="USD" value-date="2017-10-17">2618964.55</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dc5a767e-d0aa-4ff4-ab6a-f78edbef81eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-09" />
      <value currency="USD" value-date="2018-01-09">190105.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d8d1b513-177a-441f-aaad-5c5e7f3254cd">
      <transaction-type code="7" />
      <transaction-date iso-date="2018-05-01" />
      <value currency="USD" value-date="2018-05-01">162811.53</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="867dd97b-c980-484e-8009-782d284d5634">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-07" />
      <value currency="USD" value-date="2018-05-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0eb88f1f-cb88-424d-a7bf-f223d3a6f679">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-09" />
      <value currency="USD" value-date="2018-05-09">-162811.53</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e209272c-0e0a-4fd6-bd87-55b24119e748">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-19" />
      <value currency="USD" value-date="2018-10-19">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="50ceb52a-b041-42fa-b917-56e8303b5e79">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-17" />
      <value currency="USD" value-date="2018-12-17">-4250.00</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2685fcb5-a874-41cb-8bc4-c658e6977b83">
      <transaction-type code="7" />
      <transaction-date iso-date="2018-12-17" />
      <value currency="USD" value-date="2018-12-17">4250.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/TJK-T-RCTC" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-07" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31">
          <comment>
            <narrative>Numerator: 872.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 458.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 458.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 346.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 540.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 399.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2018-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 801.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 583.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 575.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 8.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 226.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 357.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="52">
          <comment>
            <narrative>Numerator: 195; Denominator: 375.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="62.6">
            <comment>
              <narrative>Numerator: 112; Denominator: 179.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="64.8">
            <comment>
              <narrative>Numerator: 116; Denominator: 179.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="69.8">
            <comment>
              <narrative>Numerator: 132; Denominator: 189.</narrative>
            </comment>
          </target>
          <actual value="73.7">
            <comment>
              <narrative>Numerator: 112; Denominator: 152.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2018-03-31" />
          <target value="74.6">
            <comment>
              <narrative>Numerator: 141; Denominator: 189.</narrative>
            </comment>
          </target>
          <actual value="30.2">
            <comment>
              <narrative>Numerator: 118; Denominator: 391.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>DOTS-other 1: Coverage of first-line drug susceptibility testing: percentage of patients receiving DST to FLDs among all notified culture-positive TB patients (new and previously treated)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>DOTS-other 1: Coverage of first-line drug susceptibility testing: percentage of patients receiving DST to FLDs among all notified culture-positive TB patients (new and previously treated)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="46">
          <comment>
            <narrative>Numerator: 1917; Denominator: 4170.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 2978; Denominator: 4582.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2018-03-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 4531; Denominator: 5664.</narrative>
            </comment>
          </target>
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 1556; Denominator: 1791.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31">
          <comment>
            <narrative>Numerator: 5576.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5473; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 334; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 2595; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3212; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 141; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2960.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2960.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2672.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2018-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4208.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3979.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3719.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 260.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1785.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2194.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 121.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="2475" />
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="1366" />
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="1366" />
          <actual value="1337" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="1444" />
          <actual value="1526" />
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2018-03-31" />
          <target value="2209" />
          <actual value="1868" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="84.3">
          <comment>
            <narrative>Numerator: 1847; Denominator: 2192.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="84.5">
            <comment>
              <narrative>Numerator: 935; Denominator: 1106.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="84.5">
            <comment>
              <narrative>Numerator: 934; Denominator: 1106.</narrative>
            </comment>
          </target>
          <actual value="88.3">
            <comment>
              <narrative>Numerator: 1037; Denominator: 1174.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 1006; Denominator: 1184.</narrative>
            </comment>
          </target>
          <actual value="87.3">
            <comment>
              <narrative>Numerator: 1291; Denominator: 1479.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2018-03-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 1539; Denominator: 1811.</narrative>
            </comment>
          </target>
          <actual value="89.8">
            <comment>
              <narrative>Numerator: 1564; Denominator: 1741.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="89">
          <comment>
            <narrative>Numerator: 3367; Denominator: 3784.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="92">
            <comment>
              <narrative>Numerator: 1541; Denominator: 1675.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 1558; Denominator: 1675.</narrative>
            </comment>
          </target>
          <actual value="98.7">
            <comment>
              <narrative>Numerator: 4714; Denominator: 4777.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1410; Denominator: 1484.</narrative>
            </comment>
          </target>
          <actual value="99.8">
            <comment>
              <narrative>Numerator: 4319; Denominator: 4327.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2018-03-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 1424; Denominator: 1484.</narrative>
            </comment>
          </target>
          <actual value="99.6">
            <comment>
              <narrative>Numerator: 5040; Denominator: 5062.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="80">
          <comment>
            <narrative>Numerator: 128; Denominator: 161.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="85.9">
            <comment>
              <narrative>Numerator: 134; Denominator: 156.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="88.1">
            <comment>
              <narrative>Numerator: 74; Denominator: 84.</narrative>
            </comment>
          </target>
          <actual value="91.3">
            <comment>
              <narrative>Numerator: 94; Denominator: 103.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="89.2">
            <comment>
              <narrative>Numerator: 149; Denominator: 167.</narrative>
            </comment>
          </target>
          <actual value="85">
            <comment>
              <narrative>Numerator: 91; Denominator: 107.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2018-03-31" />
          <target value="91">
            <comment>
              <narrative>Numerator: 151; Denominator: 166.</narrative>
            </comment>
          </target>
          <actual value="86.4">
            <comment>
              <narrative>Numerator: 178; Denominator: 206.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="90.4">
          <comment>
            <narrative>Numerator: 5656; Denominator: 6260.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target value="92">
            <comment>
              <narrative>Numerator: 6224; Denominator: 6766.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="94.9">
            <comment>
              <narrative>Numerator: 6900; Denominator: 7270.</narrative>
            </comment>
          </target>
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 5850; Denominator: 6241.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2018-03-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 6912; Denominator: 7200.</narrative>
            </comment>
          </target>
          <actual value="94.6">
            <comment>
              <narrative>Numerator: 5937; Denominator: 6279.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-TJK-T-RCTC-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Fight against Tuberculosis in Tajikistan - Tajikistan (01-Apr-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Tajikistan, Tuberculosis, Republican Center of Tuberculosis Control - Tajikistan</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the burden of TB and DR-TB burden in Tajikistan. Objectives: To ensure universal access to early and quality diagnosis of all forms of TB including M/XDR-TB; To ensure universal access to quality patient-centered treatment of all forms of TB including M/XDR-TB with appropriate patient support; Strengthening human and institutional capacity of the health system to manage TB and MDR-TB services.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
    </participating-org>
    <other-identifier ref="TJK-T-RCTCP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-04-01" />
    <activity-date type="2" iso-date="2018-04-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="TJ" percentage="100">
      <narrative>Tajikistan</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="82.73">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="17.27">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="14.97">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="0.9">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="054acddf-7eaa-4d8d-b6a4-97e7f6a59a1e" percentage="1.4">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Capacity building for health workers, including those at community level</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="36.15">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="01da3c87-13e1-4ce3-9c23-a3d4fd565967" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Collaborative activities with other programs and sectors (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a4cf383e-48f0-4449-bdfd-4fefcc86f8e3" percentage="1.56">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="44.92">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">2661456.12</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">3375609.12</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">5135294.01</value>
    </budget>
    <capital-spend percentage="10.76" />
    <transaction ref="13ceaa0a-f3de-4e40-9c39-ab5f1a915dc4">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-07" />
      <value currency="USD" value-date="2018-05-07">3952307.42</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3b1d2851-3abd-4903-8ccd-56fa6105a7ca">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-08" />
      <value currency="USD" value-date="2018-05-08">378170.83</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="acebefc3-fb4e-4d99-be03-ee91dd63fa68">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-06-29" />
      <value currency="USD" value-date="2018-06-29">337474.65</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c651959f-fa77-4c2f-8e0a-7e9f69fa71fe">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-07-03" />
      <value currency="USD" value-date="2018-07-03">410609.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f9fda576-9970-4dd1-8831-c88e59272df7">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-07-24" />
      <value currency="USD" value-date="2018-07-24">429062.30</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="70de0bb4-964f-4ffa-9df7-adc38eb584a0">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-04" />
      <value currency="USD" value-date="2018-10-04">397661.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4c571fb3-c5f4-430c-a987-6275d2a76e6b">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-04" />
      <value currency="USD" value-date="2018-10-04">736314.14</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8035aa41-f341-4d32-b68f-d8649b67255d">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-11" />
      <value currency="USD" value-date="2018-12-11">28680.35</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a6f3902f-2ada-47b5-8df2-0ce872289d6e">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-15" />
      <value currency="USD" value-date="2019-01-15">422434.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c806228b-4970-4df7-aafd-f60bd2474b4d">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-15" />
      <value currency="USD" value-date="2019-01-15">28680.35</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6405fa9a-f3c2-4c42-884a-edb351d661c7">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-15" />
      <value currency="USD" value-date="2019-01-15">8691.69</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6dc4c2ee-c858-4330-8b80-16a78e498980">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-22" />
      <value currency="USD" value-date="2019-01-22">615346.22</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c3776ecb-866f-4838-b0a9-8ae46d342c3d">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-03-21" />
      <value currency="USD" value-date="2019-03-21">-159182.89</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="634f14a6-e909-4633-93e1-a26db8b24463">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-03-21" />
      <value currency="USD" value-date="2019-03-21">421975.89</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="99740470-87cc-46c2-aba9-ee9a2078ea0e">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-22" />
      <value currency="USD" value-date="2019-03-22">421975.89</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a85b0226-9eb1-4863-81eb-2acc0de129f4">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f02604b9-6a06-46df-acfb-f17d7317aaf4">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-06-17" />
      <value currency="USD" value-date="2019-06-17">5153605.05</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8d49acb9-55eb-4a8b-9a69-72b9b79870a0">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-18" />
      <value currency="USD" value-date="2019-06-18">107574.34</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7a6c5e33-55fc-405b-b416-0600fd40821c">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-18" />
      <value currency="USD" value-date="2019-06-18">1278972.01</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4bf4d448-a34f-4ad8-83d7-f658b4d86277">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-17" />
      <value currency="USD" value-date="2019-12-17">100000.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="35ea2c56-0217-45f9-93b9-d26f8ea8565c">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-28" />
      <value currency="USD" value-date="2020-01-28">268778.13</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c87c83ce-3a5f-4bce-a72e-15bf587fd04d">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-06" />
      <value currency="USD" value-date="2020-02-06">330609.40</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d7741d78-3659-4e12-baa1-0a15d70f349a">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-18" />
      <value currency="USD" value-date="2020-02-18">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="300bae57-2d69-4675-9845-0b64290c850e">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-27" />
      <value currency="USD" value-date="2020-02-27">499211.53</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8c666a9f-8619-4d4e-a382-6c470b5f9b26">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-03-20" />
      <value currency="USD" value-date="2020-03-20">9320.14</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e953aae9-aeb3-4b59-b535-5167da9d301c">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-15" />
      <value currency="USD" value-date="2020-05-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8a0bb0ca-1598-4d2f-a917-60d84da56329">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-24" />
      <value currency="USD" value-date="2020-06-24">633052.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="503dc232-388c-4f76-aff0-ce6758758eb4">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-24" />
      <value currency="USD" value-date="2020-06-24">1605021.97</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9e81710a-dbc6-47ad-b0dc-0afef7992ef9">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-24" />
      <value currency="USD" value-date="2020-06-24">265076.32</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a4c1ec5d-fef6-4bde-8349-18770c4b5d69">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-02" />
      <value currency="USD" value-date="2020-07-02">16487.30</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="65b6195f-dc39-4cde-b2b4-d5860d760e73">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-15" />
      <value currency="USD" value-date="2020-07-15">30597.45</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6881a977-1b33-4323-8c82-bc45e924ebb3">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-08-03" />
      <value currency="USD" value-date="2020-08-03">370618.11</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="65cedf7f-0c05-4e44-8d4f-f9da11e5a09d">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-08-12" />
      <value currency="USD" value-date="2020-08-12">-370618.11</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2749274d-5c66-4b98-8bc9-63c1e89987e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-08-13" />
      <value currency="USD" value-date="2020-08-13">951191.43</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="520c3bd6-293c-462f-8146-496f45d804ed">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-08-13" />
      <value currency="USD" value-date="2020-08-13">-8904.46</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6daed6d1-0088-49de-8ab0-b0316f2b134c">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-19" />
      <value currency="USD" value-date="2020-08-19">951191.43</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="63f1fd19-c243-4c11-b141-4d41fa108cdf">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-10-02" />
      <value currency="USD" value-date="2020-10-02">215953.24</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0f0e431a-b8c5-4f80-9d24-cc1acecf651d">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-07" />
      <value currency="USD" value-date="2020-10-07">65953.24</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="618b6dfe-ca81-44e9-a9bc-f6da1a6e34ef">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-07" />
      <value currency="USD" value-date="2020-10-07">75000.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e7782beb-676e-4012-9077-653bd1972255">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-25" />
      <value currency="USD" value-date="2020-11-25">75000.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ce91074d-cd3e-419c-b2fc-2e62c111a38f">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9b9dbb0f-1d92-49a4-aead-c9e386e13596">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-09-01" />
      <value currency="USD" value-date="2021-09-01">36701.62</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c508deb7-b42c-42ff-bd45-e12c482b16aa">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-30" />
      <value currency="USD" value-date="2021-09-30">-36701.62</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7dd4980f-0253-41b2-b6a5-deb63e3fdeae">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-11-15" />
      <value currency="USD" value-date="2021-11-15">12448.63</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1c7d834e-401e-4d57-a049-9b21d13877cd">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-23" />
      <value currency="USD" value-date="2021-11-23">-12448.63</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d384d397-8508-4924-81ef-0de0969c5f4e">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-01" />
      <value currency="USD" value-date="2021-12-01">2581.93</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="05e105dc-73b4-4f6c-9634-8acfe5d55136">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-03" />
      <value currency="USD" value-date="2021-12-03">6359.68</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c4d5d74c-93ec-4357-8d65-adf5868831af">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-07" />
      <value currency="USD" value-date="2021-12-07">-2581.93</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a38cafcd-afa3-4614-acdd-57e2ae0ee15e">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">6359.68</value>
      <description>
        <narrative>Global Fund disbursement to TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e89750dc-0ade-44d5-8d99-9bc8cfe9fdaa">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-16" />
      <value currency="USD" value-date="2021-12-16">23165.95</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d06ddff4-7b00-4f11-a7cf-a9a9a9462447">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-20" />
      <value currency="USD" value-date="2021-12-20">-23165.95</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cfda3f1e-60e6-4ecc-a70e-ea756cdd638b">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">249470.48</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6ea82d1a-095a-40de-9b7f-51dc14d4c2d3">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-22" />
      <value currency="USD" value-date="2021-12-22">-249470.48</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fd79c211-1cf1-4964-bf95-f9accd4dedc7">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-01" />
      <value currency="USD" value-date="2022-10-01">21145.21</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ce274840-ea4e-43a8-955d-df7cdbb37b31">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-21145.21</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dca602cf-9cae-4cf5-8a66-ee7dd26c16da">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-11-09" />
      <value currency="USD" value-date="2022-11-09">11492.12</value>
      <description>
        <narrative>Funds returned to the Global Fund from TJK-T-RCTCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="999ed622-509b-4de9-9983-d4ff6b81ac6f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-11" />
      <value currency="USD" value-date="2022-11-11">-11492.12</value>
      <description>
        <narrative>Global Fund commitment to TJK-T-RCTCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="TJK-T-RCTCP02-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">1044863.00</value>
      <description>
        <narrative>Expenditure reported by Republican Center of Tuberculosis Control - Tajikistan for TJK-T-RCTCP02, Apr 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
    </transaction>
    <transaction ref="TJK-T-RCTCP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">1977690.11</value>
      <description>
        <narrative>Expenditure reported by Republican Center of Tuberculosis Control - Tajikistan for TJK-T-RCTCP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
    </transaction>
    <transaction ref="TJK-T-RCTCP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">6537311.00</value>
      <description>
        <narrative>Expenditure reported by Republican Center of Tuberculosis Control - Tajikistan for TJK-T-RCTCP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
    </transaction>
    <transaction ref="TJK-T-RCTCP02-EXP-20210930">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-09-30" />
      <value currency="USD" value-date="2021-09-30">1026230.19</value>
      <description>
        <narrative>Expenditure reported by Republican Center of Tuberculosis Control - Tajikistan for TJK-T-RCTCP02, Jan 2021 to Sep 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Republican Center of Tuberculosis Control - Tajikistan</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/TJK-T-RCTC" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-07" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 748.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 727; Denominator: 748; Percentage: 97.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 727; Denominator: 748; Percentage: 97.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 727; Denominator: 748; Percentage: 97.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 727; Denominator: 748; Percentage: 97.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 727; Denominator: 748; Percentage: 97.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 748; Percentage: 2.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 748; Percentage: 2.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 748; Percentage: 2.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 748; Percentage: 2.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 748; Percentage: 2.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 296; Denominator: 748; Percentage: 40%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 296; Denominator: 748; Percentage: 40%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 296; Denominator: 748; Percentage: 40%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 296; Denominator: 748; Percentage: 40%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 296; Denominator: 748; Percentage: 40%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 452; Denominator: 748; Percentage: 60%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 452; Denominator: 748; Percentage: 60%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 452; Denominator: 748; Percentage: 60%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 452; Denominator: 748; Percentage: 60%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 452; Denominator: 748; Percentage: 60%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 628.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 546.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 534; Denominator: 546; Percentage: 97.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 12; Denominator: 546; Percentage: 2.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 227; Denominator: 546; Percentage: 41.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 319; Denominator: 546; Percentage: 58.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 428.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 397.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 388; Denominator: 397; Percentage: 97.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 9; Denominator: 397; Percentage: 2.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 149; Denominator: 397; Percentage: 37.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 248; Denominator: 397; Percentage: 62.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 867.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 875.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 857; Denominator: 875; Percentage: 97.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 18; Denominator: 875; Percentage: 2.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 355; Denominator: 875; Percentage: 40.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 520; Denominator: 875; Percentage: 59.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 438.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 259.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 254; Denominator: 259; Percentage: 98.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 5; Denominator: 259; Percentage: 1.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 109; Denominator: 259; Percentage: 42.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 150; Denominator: 259; Percentage: 57.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 870.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 519.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 513; Denominator: 519; Percentage: 98.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 6; Denominator: 519; Percentage: 1.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 217; Denominator: 519; Percentage: 41.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 302; Denominator: 519; Percentage: 58.2%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases of XDR TB enrolled on treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases of XDR TB enrolled on treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="61" />
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-12-31" />
          <target value="60" />
          <actual value="63" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="44" />
          <actual value="37" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90" />
          <actual value="60" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="48" />
          <actual value="22" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="89" />
          <actual value="30" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 693.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 672; Denominator: 693; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 672; Denominator: 693; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 672; Denominator: 693; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 672; Denominator: 693; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 672; Denominator: 693; Percentage: 96.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 693; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 693; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 693; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 693; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 21; Denominator: 693; Percentage: 3.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 270; Denominator: 693; Percentage: 38.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 270; Denominator: 693; Percentage: 38.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 270; Denominator: 693; Percentage: 38.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 270; Denominator: 693; Percentage: 38.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 270; Denominator: 693; Percentage: 38.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 423; Denominator: 693; Percentage: 61.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 423; Denominator: 693; Percentage: 61.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 423; Denominator: 693; Percentage: 61.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 423; Denominator: 693; Percentage: 61.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 423; Denominator: 693; Percentage: 61.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 32.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 32.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 32.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 32.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 32.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 584.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 660.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 602; Denominator: 612; Percentage: 98.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 10; Denominator: 612; Percentage: 1.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 254; Denominator: 612; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 358; Denominator: 612; Percentage: 58.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 149; Denominator: 612; Percentage: 24.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 401.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 373.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 366; Denominator: 373; Percentage: 98.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 7; Denominator: 373; Percentage: 1.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 143; Denominator: 373; Percentage: 38.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 230; Denominator: 373; Percentage: 61.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 82; Denominator: 373; Percentage: 22%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 812.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 668.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 646; Denominator: 668; Percentage: 96.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 22; Denominator: 668; Percentage: 3.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 268; Denominator: 668; Percentage: 40.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 400; Denominator: 668; Percentage: 59.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 233; Denominator: 668; Percentage: 34.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 412.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 227.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 217; Denominator: 227; Percentage: 95.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 10; Denominator: 227; Percentage: 4.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 99; Denominator: 227; Percentage: 43.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 128; Denominator: 227; Percentage: 56.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 150; Denominator: 227; Percentage: 66.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 822.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 493.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 473; Denominator: 493; Percentage: 95.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 20; Denominator: 493; Percentage: 4.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 203; Denominator: 493; Percentage: 41.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 290; Denominator: 493; Percentage: 58.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 323; Denominator: 493; Percentage: 65.5%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="56.16">
          <comment>
            <narrative>Numerator: 3500; Denominator: 6232.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-12-31" />
          <target value="58" />
          <actual value="74.1">
            <comment>
              <narrative>Numerator: 3450; Denominator: 4659.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="65" />
          <actual value="71.9">
            <comment>
              <narrative>Numerator: 1980; Denominator: 2753.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="72" />
          <actual value="79.9">
            <comment>
              <narrative>Numerator: 2625; Denominator: 3287.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="80" />
          <actual value="81.6">
            <comment>
              <narrative>Numerator: 2127; Denominator: 2608.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="88" />
          <actual value="99.2">
            <comment>
              <narrative>Numerator: 2318; Denominator: 2336.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="5.57">
          <comment>
            <narrative>Numerator: 38; Denominator: 682.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-12-31" />
          <target value="5.1" />
          <actual value="5.9">
            <comment>
              <narrative>Numerator: 35; Denominator: 591.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="4.8" />
          <actual value="3.7">
            <comment>
              <narrative>Numerator: 16; Denominator: 431.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="4.6" />
          <actual value="3.4">
            <comment>
              <narrative>Numerator: 12; Denominator: 350.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="4.4" />
          <actual value="2">
            <comment>
              <narrative>Numerator: 7; Denominator: 351.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="4.2" />
          <actual value="19">
            <comment>
              <narrative>Numerator: 49; Denominator: 258.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="61.63">
          <comment>
            <narrative>Numerator: 461; Denominator: 748.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-12-31" />
          <target value="65" />
          <actual value="85.4">
            <comment>
              <narrative>Numerator: 181; Denominator: 212.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="68" />
          <actual value="70.8">
            <comment>
              <narrative>Numerator: 68; Denominator: 96.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="71" />
          <actual value="85.6">
            <comment>
              <narrative>Numerator: 184; Denominator: 215.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="74" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 130; Denominator: 130.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="77" />
          <actual value="93.6">
            <comment>
              <narrative>Numerator: 103; Denominator: 110.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="54.81">
          <comment>
            <narrative>Numerator: 3416; Denominator: 6232.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-12-31" />
          <target value="65" />
          <actual value="73">
            <comment>
              <narrative>Numerator: 3192; Denominator: 4373.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="70" />
          <actual value="68.5">
            <comment>
              <narrative>Numerator: 2115; Denominator: 3088.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="75" />
          <actual value="80">
            <comment>
              <narrative>Numerator: 4602; Denominator: 5751.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="80" />
          <actual value="73.5">
            <comment>
              <narrative>Numerator: 1731; Denominator: 2354.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="85" />
          <actual value="78.6">
            <comment>
              <narrative>Numerator: 3259; Denominator: 4147.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="94">
          <comment>
            <narrative>Numerator: 5858; Denominator: 6232.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-12-31" />
          <target value="94" />
          <actual value="94.5">
            <comment>
              <narrative>Numerator: 4134; Denominator: 4373.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="94.5" />
          <actual value="85.6">
            <comment>
              <narrative>Numerator: 2644; Denominator: 3088.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="95" />
          <actual value="95.2">
            <comment>
              <narrative>Numerator: 5475; Denominator: 5751.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="95.5" />
          <actual value="91.8">
            <comment>
              <narrative>Numerator: 2160; Denominator: 2354.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="96" />
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 3884; Denominator: 4147.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>